Coya Therapeutics (COYA) EBIT Margin (2023 - 2026)
Coya Therapeutics (COYA) recorded EBIT Margin of -2891.13% in Q2 2026, up 1029.34 percentage points from -3920.47% a year earlier and up 151.00 percentage points from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) EBIT Margin (2023 - 2026) Analysis & Trends
On a TTM basis, Coya Therapeutics' EBIT Margin came in at -288.70% as of Jun 30, 2026, up 5053.59 percentage points year-over-year; for FY2025, it was -283.87%, up 201.49 percentage points from FY2024.
- Across earlier years, EBIT Margin came in at -485.35% in FY2024 (-353.68 pp) and -131.67% in FY2023.
- Quarterly EBIT Margin has ranged from -209031.51% in Q4 2024 to 30.24% in Q4 2023 over the past five years.
- On a year-over-year basis, EBIT Margin rose in three of the last six quarters, with an average year-over-year change of -283.08 percentage points.
- Per Business Quant, the preceding three quarters came in at -3042.13% (Q1 2026), -152.30% (Q4 2025) and -68.26% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Coya Therapeutics | 74.13 Mn | -102.42 Mn | - | -4,676.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -4,676.21% |
| Jun 30, 2026 | -2,891.13% |
| Mar 31, 2026 | -3,042.13% |
| Dec 31, 2025 | -152.30% |
| Sep 30, 2025 | -68.26% |
| Jun 30, 2025 | -3,920.47% |
| Mar 31, 2025 | -2,976.89% |
| Dec 31, 2024 | -209,031.51% |
| Jun 30, 2024 | -94.48% |
| Mar 31, 2024 | -4,322.84% |
| Dec 31, 2023 | 30.24% |
API Access
Coya Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();